Analysts may not have crystal balls, but they’re pretty bullish on Vertex’s 2028 outlook, despite its rocky stock performance ...

Morgan Stanley raised the firm’s price target on Vertex (VERX) to $60 from $57 and keeps an Overweight rating on the shares. The company’s ...

In recent years, large language models (LLMs) have made significant progress in generating human-like text, translating ...

Mistral Small 3.1, a 24B parameter AI marvel outshines industry giants like Gemma 3 and GPT-4o mini. Download Mistral Small 3 ...

Shares of Vertex Pharmaceuticals have received an average “Moderate Buy” rating from 26 brokerages. Analysts are divided, ...

Despite early success, Verona's lack of specific 2025 guidance and competition from Dupixent and other drugs raise concerns.

About the company: SurgeGraph Vertex is an SEO AI writing tool with a mission to redefine content writing through humanized, ...

The biotech will commit $150 million to an alliance that hands it significant production capacity for a closely watched ...

Vertex Pharmaceuticals Inc.’s new non-opioid painkiller is being placed on a tier that means it might be costlier than other pain treatments on UnitedHealth Group Inc.’s approved drug lists.

Artificial intelligence is growing in a big way - and when it comes to writing, it's ChatGPT that's been snatching all the headlines of late, with its ability to generate short- and long-form ...

This may not always be in the form of an official concentration since creative writing is often a concentration within an English degree program. Still, you may be able to tailor your studies to ...